Countdown, a nonprofit accelerating mitochondrial science and medicine across the full spectrum of human health, announced a new research grant awarded to Dr.
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces financial results for the first quarter ended March 31, 2026. Below are ...
Repeated power outages at a forensic laboratory and several schools in Pretoria raise serious concerns over service delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results